Andy Grove: Wrong again (and again) about drug discovery
Former Intel chairman Andrew Grove is assailing the U.S. medical establishment again, this time with a jeremiad in which he blames the drug industry for not moving at the speed of Moore’s law. Of course, there’s plenty in the drug industry to criticize, but over at VentureBeat Life Sciences, we look at why Grove’s specific analysis is way off base, and how he also seems to overlook a major but little-noticed problem in the system — one that he’s in an excellent position to do something about. Check it out here.
Next Story: Life sciences briefing: Friday, Nov. 9, 2007
Previous Story: What Andy Grove still gets wrong about the life sciences — and how he could help fix them
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.